Dr. Anthony Fauci, the White House’s chief coronavirus adviser in the United States, said that experimental antiviral drug would be developed by Gilead Sciences Company. He said that it would be used as a standard drug in the treatment of people infected with COVID-19 virus.
According to aljazeera.com, the results of a clinical study show that the antiviral drug belonging to the class of nucleotide analogues, allows you to restore the function of the organs of patients with coronavirus and reduce mortality.
The results, published by the company, show that patients taking the drug recover faster than 31% of patients receiving coated tablets.
The U.S. Food and Drug Administration is currently in talks with the manufacturer to deliver the drug to healthl facilities as soon as possible.